Posted by on January 23, 2018 4:21 pm
Tags:
Categories: Crispr

Salk scientists modify CRISPR to epigenetically treat diabetes, kidney disease, muscular dystrophy

Salk scientists have created a new version of the CRISPR/Cas9 genome editing technology that allows them to activate genes without creating breaks in the DNA, potentially circumventing a major hurdle to using gene editing technologies to treat human diseases. Read more here: https://www.salk.edu/news-release/salk-scientists-modify-crispr-epigenetically-treat-diabetes-kidney-disease-muscular-dystrophy/

Leave a Reply